Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties
Authors
Lulzime Ballazhi
Faculty of Pharmacy, Center of Biomolecular Pharmaceutical Analyses University “Ss Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Faik Imeri
Institute of Physiology, University of Zürich, Zürich, Switzerland
Ahmed Jashari
Faculty of Natural Sciences & Mathematics State University of Tetovo, Tetovo, Macedonia (the former Yugoslav Republic of)
Emil Popovski
Institute of Chemistry, Faculty of Natural Sciences and Mathematics, University “Ss. Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Goran Stojković
Institute of Chemistry, Faculty of Natural Sciences and Mathematics, University “Ss. Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Aleksandar J. Dimovski
Faculty of Pharmacy, Center of Biomolecular Pharmaceutical Analyses University “Ss Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Bozhana Mikhova
Bulgarian Academy of Sciences Institute of Organic Chemistry with Centre of Phytochemistry, Sofia, Bulgaria
Kristina Mladenovska
Faculty of Pharmacy, Center of Biomolecular Pharmaceutical Analyses University “Ss Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Language: English
Page range: 35 - 52
Accepted on: Sep 21, 2016
Published on: Feb 21, 2017
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2017 Lulzime Ballazhi, Faik Imeri, Ahmed Jashari, Emil Popovski, Goran Stojković, Aleksandar J. Dimovski, Bozhana Mikhova, Kristina Mladenovska, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.